1. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol. 1988;15(2):276–83.
2. Furst D, et al. Systemic sclerosis – continuing progress in developing clinical measures of response. J Rheumatol. 2007;34(5):1194–200.
3. LeRoy EC, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
4. Black CM, et al. HLA antigens, autoantibodies and clinical subsets in scleroderma. Br J Rheumatol. 1984;23(4):267–71.
5. Bolster MB, Silver RM. Lung disease in systemic sclerosis (scleroderma). Baillieres Clin Rheumatol. 1993;7(1):79–97.